BMC Cancer

Papers
(The H4-Index of BMC Cancer is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Gut microbiome and its role in colorectal cancer152
Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis110
Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program105
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protoc98
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)88
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis84
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma83
Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis82
Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling80
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients79
Association between heavy metals and colon cancer: an ecological study based on geographical information systems in North-Eastern Iran77
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 201976
Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis75
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma75
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years70
Fusobacterium nucleatum and oral cancer: a critical review67
Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis65
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study58
Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database58
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population55
Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer54
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study54
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affe53
A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma52
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma51
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results51
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial)51
PTEN loss correlates with T cell exclusion across human cancers50
Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews50
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma49
Designing an exercise intervention for adult survivors of childhood cancers48
Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing46
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) rando46
Homologous recombination proficiency in ovarian and breast cancer patients46
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis45
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review44
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma44
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer44
The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma44
The mixed blessing of AMPK signaling in Cancer treatments42
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer42
Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study42
0.075053930282593